Mark Bock Email

VP Chemistry . NodThera

Little Chesterford,

Location

Current Roles

Employees:
32
Revenue:
$5M
About
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We're building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Lexington, MA; all united by our shared ambition, enthusiasm and creativity.
NodThera Address
265 Franklin St.
Little Chesterford, null
NodThera Email

Past Companies

NodThera LimitedVP of Chemistry
IndependentMedicinal Chemistry Consultant
NovartisExecutive Director of Global Discovery Chemistry

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.